11:09 AM EDT, 10/24/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were little changed late Friday morning, edging 0.03% higher to 1,593.26 on the S&P Europe Select ADR Index, which is up about 0.5% for the week.

From continental Europe, the gainers were led by pharmaceutical company Sanofi ( SNY ) and biotech firm Evaxion ( EVAX ) , which rose 3.8% and 4.8% respectively. They were followed by biopharmaceutical companies DBV Technologies ( DBVT ) and Genfit ( GNFT ) , which were up 4.9% and 1.2% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and software firm SAP (SAP), which fell 7.9% and 2% respectively. They were followed by petroleum refiner Equinor ( EQNR ) and medical device manufacturer EDAP TMS ( EDAP ) , which were down 2.8% and 2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Akari Therapeutics ( AKTX ) , which advanced 5% and 2.8% respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and hospitality company InterContinental Hotels Group ( IHG ) , which increased 2.7% and 1.9% respectively.

The decliners from the UK and Ireland were led by pharmaceutical company GSK (GSK) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which dropped 5.1% and 9.7% respectively.